Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,662.98
(
-0.33%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 112128

Thursday, 02/23/2012 10:43:58 PM

Thursday, February 23, 2012 10:43:58 PM

Post# of 257268
FDA advisory panel votes 12-2 in favor of FRX’s aclidinium bromide for COPD:

http://finance.yahoo.com/news/Forest-Almirall-Announce-bw-2713059705.html?x=0

Forest and Almirall anticipate receiving FDA feedback on the filing in the second quarter of calendar year 2012.

Odd wording… is this when the PDUFA date is?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today